Everence Capital Management Inc. Grows Stock Holdings in Humana Inc. (NYSE:HUM)

Everence Capital Management Inc. raised its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 57.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,530 shares of the insurance provider's stock after acquiring an additional 2,020 shares during the period. Everence Capital Management Inc.'s holdings in Humana were worth $1,403,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the business. Moors & Cabot Inc. boosted its holdings in Humana by 2.5% during the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider's stock valued at $519,000 after acquiring an additional 40 shares during the period. OLD National Bancorp IN lifted its position in Humana by 1.8% in the third quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider's stock valued at $828,000 after purchasing an additional 45 shares during the last quarter. Your Advocates Ltd. LLP boosted its stake in shares of Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares during the period. Brooklyn Investment Group grew its holdings in shares of Humana by 6.7% in the third quarter. Brooklyn Investment Group now owns 736 shares of the insurance provider's stock worth $233,000 after purchasing an additional 46 shares during the last quarter. Finally, Demars Financial Group LLC grew its holdings in shares of Humana by 2.7% in the third quarter. Demars Financial Group LLC now owns 1,950 shares of the insurance provider's stock worth $618,000 after purchasing an additional 52 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.32% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on HUM shares. Truist Financial dropped their price target on shares of Humana from $400.00 to $260.00 and set a "hold" rating for the company in a research report on Friday, October 11th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Humana from $349.00 to $250.00 and set a "hold" rating for the company in a report on Thursday, October 3rd. KeyCorp initiated coverage on Humana in a report on Friday, October 11th. They set a "sector weight" rating on the stock. Wells Fargo & Company dropped their price objective on Humana from $387.00 to $290.00 and set an "overweight" rating for the company in a report on Monday, November 4th. Finally, Sanford C. Bernstein raised Humana from a "market perform" rating to an "outperform" rating and set a $308.00 target price on the stock in a research note on Tuesday, October 8th. Twenty equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $300.50.

Humana Stock Up 3.9 %

NYSE:HUM traded up $9.82 during trading hours on Friday, reaching $262.47. 1,373,823 shares of the company traded hands, compared to its average volume of 1,126,161. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The business's 50-day moving average price is $272.60 and its two-hundred day moving average price is $313.96. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $471.37. The stock has a market capitalization of $31.60 billion, a P/E ratio of 23.25, a P/E/G ratio of 2.12 and a beta of 0.55.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Analysts predict that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.35%. Humana's payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.